Item 8.01 Other Events.
On June 11, 2009, Medicis Pharmaceutical Corporation ("Medicis") filed suit against Ranbaxy Inc. and Ranbaxy Laboratories Ltd. (collectively, "Ranbaxy") in the United States District Court for the District of Delaware seeking an adjudication that Ranbaxy has infringed one or more claims of Medicis' U.S. Patent No. 5,908,838 (the "'838 Patent") by submitting to the U.S. Food and Drug Administration an Abbreviated New Drug Application for a generic version of SOLODYNŽ in its form of 135mg strength. The relief requested by Medicis includes a request for a permanent injunction preventing Ranbaxy from infringing the '838 patent by selling a generic version of SOLODYNŽ.

---